Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Journal of Allergy and Clinical Immunology

Volumn 140, Issue 4, 2017, Pages 950-958

  Brożek, Jan L ^a   Bousquet, Jean ^b   Agache, Ioana ^c   Agarwal, Arnav ^a,d   Bachert, Claus ^e   Bosnic Anticevich, Sinthia ^f   Brignardello Petersen, Romina ^a   Canonica, G Walter ^g   Casale, Thomas ^h   Chavannes, Niels H ⁱ   Correia de Sousa, Jaime ^j   Cruz, Alvaro A ^k   Cuello Garcia, Carlos A ^a   Demoly, Pascal ^b   Dykewicz, Mark ^l   Etxeandia Ikobaltzeta, Itziar ^a,m   Florez, Ivan D ^a,n   Fokkens, Wytske ^o   Fonseca, Joao ^p   Hellings, Peter W ^o   Klimek, Ludger ^q   Kowalski, Sergio ^a   Kuna, Piotr ^r   Laisaar, Kaja Triin ^s   Larenas Linnemann, Désirée E ^t   Lødrup Carlsen, Karin C ^u   Manning, Peter J ^v   Meltzer, Eli ^w   Mullol, Joaquim ^x   Muraro, Antonella ^y   O'Hehir, Robyn ^z   Ohta, Ken ^aa   Panzner, Petr ^ab   Papadopoulos, Nikolaos ^ac,ad   Park, Hae Sim ^ae   Passalacqua, Gianni ^af   Pawankar, Ruby ^ag   Price, David ^ah   Riva, John J ^a   Roldán, Yetiani ^a   Ryan, Dermot ^ai   Sadeghirad, Behnam ^aj   Samolinski, Boleslaw ^ak   Schmid Grendelmeier, Peter ^al   Sheikh, Aziz ^ai   Togias, Alkis ^am   Valero, Antonio ^an   Valiulis, Arunas ^ao   Valovirta, Erkka ^ap   Ventresca, Matthew ^a   Wallace, Dana ^aq   Waserman, Susan ^a   Wickman, Magnus ^ar   Wiercioch, Wojtek ^a   Yepes Nuñez, Juan José ^a,n   Zhang, Luo ^as   Zhang, Yuan ^a   Zidarn, Mihaela ^at   Zuberbier, Torsten ^au   Schünemann, Holger J ^a   more..

^a MCMASTER UNIVERSITY   (Canada)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^d UNIVERSITY OF TORONTO   (Canada)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF SYDNEY   (Australia)

^g HUMANITAS UNIVERSITY   (Italy)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF MINHO   (Portugal)

^k FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^l SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m Departamento de Salud   (Spain)

ⁿ UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^o ACADEMIC MEDICAL CENTER   (Netherlands)

^p University of Porto   (Portugal)

^q Centre of Rhinology and Allergology   (Germany)

^r MEDICAL UNIVERSITY OF LODZ   (Poland)

^s UNIVERSITY OF TARTU   (Estonia)

^t Hospital Medica Sur   (Mexico)

^u OSLO UNIVERSITY HOSPITAL   (Norway)

^v ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^w UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^x HOSPITAL CLÍNIC   (Spain)

^y UNIVERSITY OF PADOVA   (Italy)

^z MONASH UNIVERSITY   (Australia)

^aa TOKYO NATIONAL HOSPITAL   (Japan)

^ab CHARLES UNIVERSITY   (Czech Republic)

^ac UNIVERSITY OF ATHENS   (Greece)

^ad UNIVERSITY OF MANCHESTER   (United Kingdom)

^ae Ajou University School of Medicine   (South Korea)

^af UNIVERSITY OF GENOA   (Italy)

^ag NIPPON MEDICAL SCHOOL   (Japan)

^ah UNIVERSITY OF ABERDEEN   (United Kingdom)

^ai UNIVERSITY OF EDINBURGH   (United Kingdom)

^aj KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^ak MEDICAL UNIVERSITY OF WARSAW   (Poland)

^al CHRISTINE KÜHNE CENTER FOR ALLERGY RESEARCH AND EDUCATION CK CARE   (Switzerland)

^am NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^an INSTITUTO DE SALUD CARLOS III   (Spain)

^ao VILNIUS UNIVERSITY   (Lithuania)

^ap UNIVERSITY OF TURKU   (Finland)

^aq NOVA SOUTHEASTERN UNIVERSITY   (United States)

^ar SACHS CHILDREN S HOSPITAL   (Sweden)

^as BEIJING INSTITUTE OF OTOLARYNGOLOGY   (China)

^at University Clinic of Pulmonary and Allergic Diseases Golnik   (Slovenia)

^au CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Allergic rhinitis; practice guideline

Indexed keywords

CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ANTIALLERGIC AGENT;

ALLERGIC RHINITIS; AMBULATORY CARE; ARTICLE; ASTHMA; DELPHI STUDY; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; GENERAL PRACTICE; HEALTH CARE COST; HEALTH EQUITY; HUMAN; JOB PERFORMANCE; LOCAL ADAPTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; SCHOOL; SYSTEMATIC REVIEW; ANIMAL; CHILD; CLINICAL DECISION MAKING; RHINITIS, ALLERGIC;

ANIMALS; ANTI-ALLERGIC AGENTS; ASTHMA; CHILD; CLINICAL DECISION-MAKING; EVIDENCE-BASED PRACTICE; HISTAMINE H1 ANTAGONISTS; HUMANS; QUALITY OF LIFE; RHINITIS, ALLERGIC;

EID: 85021395414     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.03.050     Document Type: Article

References (43)

1. Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63:suppl 86 (2008), 8–160.
2. Asher, M.I., Montefort, S., Bjorksten, B., Lai, C.K., Strachan, D.P., Weiland, S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368 (2006), 733–743.
3. Katelaris, C.H., Lee, B.W., Potter, P.C., Maspero, J.F., Cingi, C., Lopatin, A., et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy 42 (2012), 186–207.
4. Leynaert, B., Bousquet, J., Neukirch, C., Liard, R., Neukirch, F., Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 104 (1999), 301–304.
5. Gergen, P.J., Turkeltaub, P.C., The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 90 (1992), 579–588.
6. Sibbald, B., Rink, E., Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 46 (1991), 895–901.
7. Pedersen, P.A., Weeke, E.R., Asthma and allergic rhinitis in the same patients. Allergy 38 (1983), 25–29.
8. Greisner, W., Settipane, R.J., Settipane, G.A., Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 19 (1998), 185–188.
9. Guerra, S., Sherrill, D.L., Baldacci, S., Carrozzi, L., Pistelli, F., Di Pede, F., et al. Rhinitis is an independent risk factor for developing cough apart from colds among adults. Allergy 60 (2005), 343–349.
10. Corren, J., Adinoff, A.D., Buchmeier, A.D., Irvin, C.G., Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 90 (1992), 250–256.
11. Taramarcaz, P., Gibson, P.G., Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev(3), 2003, CD003570.
12. Zuberbier, T., Lotvall, J., Simoens, S., Subramanian, S.V., Church, M.K., Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy 69 (2014), 1275–1279.
13. Haahtela, T., Valovirta, E., Hannuksela, M., von Hertzen, L., Jantunen, J., Kauppi, P., et al. Finnish nationwide allergy programme at mid-term—change of direction producing results. Finnish Med J 70 (2015), 2165–2172.
14. Thanaviratananich, S., Cho, S.H., Ghoshal, A.G., Muttalif, A.R., Lin, H.C., Pothirat, C., et al. Burden of respiratory disease in Thailand: results from the APBORD observational study. Medicine (Baltimore), 95, 2016, e4090.
15. Yoo, K.H., Ahn, H.R., Park, J.K., Kim, J.W., Nam, G.H., Hong, S.K., et al. Burden of respiratory disease in Korea: an observational study on allergic rhinitis, asthma, COPD, and rhinosinusitis. Allergy Asthma Immunol Res 8 (2016), 527–534.
16. Padjas, A., Kehar, R., Aleem, S., Mejza, F., Bousquet, J., Schunemann, H.J., et al. Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. J Allergy Clin Immunol 133 (2014), 777–783.e4.
17. Bousquet, J., Lund, V.J., Van Cauwenberge, P., Bremard-Oury, C., Mounedji, N., Stevens, M.T., et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 58 (2003), 733–741.
18. Bousquet, J., Van Cauwenberge, P., Khaltaev, N., Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:suppl (2001), S147–S334.
19. Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
20. Brożek, J.L., Bousquet, J., Baena-Cagnani, C.E., Bonini, S., Canonica, G.W., Casale, T.B., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 126 (2010), 466–476.
21. Seidman, M.D., Gurgel, R.K., Lin, S.Y., Schwartz, S.R., Baroody, F.M., Bonner, J.R., et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152:suppl (2015), S1–S43.
22. Dykewicz, M.S., 7. Rhinitis and sinusitis. J Allergy Clin Immunol 111:suppl (2003), S520–S529.
23. van Cauwenberge, P., Bachert, C., Passalacqua, G., Bousquet, J., Canonica, G.W., Durham, S.R., et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 55 (2000), 116–134.
24. Guyatt, G.H., Oxman, A.D., Kunz, R., Atkins, D., Brozek, J., Vist, G., et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64 (2011), 395–400.
25. The Nordic Cochrane Centre. Review manager (RevMan) [Computer program]. Version 5.3.5. 2014, The Cochrane Collaboration, Copenhagen.
26. Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. The standardized mean difference. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008]. Available at: http://www.cochrane-handbook.org/.
27. Cohen, J., Statistical power analysis for the behavioral sciences. 2nd ed., 1988, Routledge, New York.
28. Higgins, J.P., Altman, D.G., Gotzsche, P.C., Juni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
29. Balshem, H., Helfand, M., Schunemann, H.J., Oxman, A.D., Kunz, R., Brozek, J., et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64 (2011), 401–406.
30. Schunemann, H.J., Mustafa, R., Brozek, J., Santesso, N., Alonso-Coello, P., Guyatt, G., et al. Development of the GRADE Evidence to Decision (EtD) frameworks for tests in clinical practice and public health. J Clin Epidemiol 76 (2016), 89–98.
31. Bousquet, J., Barbara, C., Bateman, E., Bel, E., Bewick, M., Chavannes, N.H., et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J 47 (2016), 1028–1033.
32. Bousquet, J., Addis, A., Adcock, I., Agache, I., Agusti, A., Alonso, A., et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 44 (2014), 304–323.
33. Bousquet, J., Pinto, J.R., Barbara, C., da Sousa, J.C., Fonseca, J., Miguel, J.P., et al. Portugal at the cross road of international chronic respiratory programmes. Rev Port Pneumol (2006) 21 (2015), 230–232.
34. Costa, D.J., Amouyal, M., Lambert, P., Ryan, D., Schunemann, H.J., Daures, J.P., et al. How representative are clinical study patients with allergic rhinitis in primary care?. J Allergy Clin Immunol 127 (2011), 920–926.e1.
35. Bousquet, J., Bachert, C., Canonica, G.W., Casale, T.B., Cruz, A.A., Lockey, R.J., et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 124 (2009), 428–433.
36. Alonso-Coello, P., Oxman, A.D., Moberg, J., Brignardello-Petersen, R., Akl, E.A., Davoli, M., et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ, 353, 2016, i2089.
37. Alonso-Coello, P., Schunemann, H.J., Moberg, J., Brignardello-Petersen, R., Akl, E.A., Davoli, M., et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ, 353, 2016, i2016.
38. Neumann, I., Brignardello-Petersen, R., Wiercioch, W., Carrasco-Labra, A., Cuello, C., Akl, E., et al. The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels. Implement Sci, 11, 2016, 93.
39. Schunemann, H.J., Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases. Curr Allergy Asthma Rep 11 (2011), 261–268.
40. Bousquet, J., Farrell, J., Crooks, G., Hellings, P., Bel, E.H., Bewick, M., et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy, 6, 2016, 29.
41. Bousquet, J., Schunemann, H.J., Hellings, P.W., Arnavielhe, S., Bachert, C., Bedbrook, A., et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol 138 (2016), 367–374.e2.
42. Bourret, R., Bousquet, J., Mercier, J., Camuzat, T., Bedbrook, A., Demoly, P., et al. MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv 51 (2015), 36–39.
43. Bousquet, J., Schunemann, H.J., Fonseca, J., Samolinski, B., Bachert, C., Canonica, G.W., et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 70 (2015), 1372–1392.